About
Visionsense develops visualization solutions that bring natural stereoscopic sight to minimally invasive surgery. Using sensor technology and proprietary software, the Visionsense system delivers depth perception, 3D HD-resolution images, and maneuvering flexibility in the smallest access diameters. With stereovision capabilities, surgeons gain enhanced tissue understanding, improved hand-eye coordination, and the confidence to use advanced articulating surgical tools. The companys VSiii solution is based on a small-diameter (starting at 4 millimeters), single-channel endoscope that delivers visual information to a stereoscopic camera that imitates an insects compound eye. The VSiii system can be used in minimally invasive neurosurgery, ENT, arthroscopy (CE only), and general surgery procedures. It has been cleared by the FDA and CE and is used clinically on a regular basis worldwide.
Funding history · 1 round · — total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is VisionSense's primary focus?
- VisionSense develops visualization solutions to provide natural stereoscopic sight for minimally invasive surgery.
- When was VisionSense founded?
- VisionSense was founded in July 1998.
- What is VisionSense's core product?
- VisionSense's core product is the VSiii system, a small-diameter, single-channel endoscope that delivers visual information to a stereoscopic camera for 3D HD-resolution images in minimally invasive surgery.
- In which medical fields is the VSiii system used?
- The VSiii system is used in minimally invasive neurosurgery, ENT, arthroscopy (CE only), and general surgery procedures.
- Has VisionSense's VSiii system received regulatory clearances?
- Yes, the VSiii system has been cleared by the FDA and CE.
- When did VisionSense receive its last known funding round?
- VisionSense received an undisclosed funding round in September 2004, with Peregrine Ventures as an investor. For full financing history, refer to startupim.
- When and by whom was VisionSense acquired?
- VisionSense was acquired by Medtronic in April 2018 for $75 million.
- What is VisionSense's current operational status?
- VisionSense is currently inactive due to its acquisition by Medtronic in April 2018.
- What was a notable legal action taken by VisionSense in 2017?
- In May 2017, VisionSense filed for an Inter Partes Review (IPR) against Novadaq's US Patent 8,892,190.